Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Transferosomes effectively deliver drugs through the skin, improving treatment for skin disorders.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Early treatment helps stop hair loss in women of color.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.